Selecting an antiarrhythmic agent for atrial fibrillation should be a patient-specific, data-driven decision
Open Access
- 1 October 1998
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 82 (7) , 72N-81N
- https://doi.org/10.1016/s0002-9149(98)00588-8
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- The canadian registry of atrial fibrillation: a noninterventional follow-up of patients after the first diagnosis of atrial fibrillationThe American Journal of Cardiology, 1998
- Atrial fibrillation trials: will they teach us what we need to know?The American Journal of Cardiology, 1998
- Rhythm Management in Atrial Fibrillation—With a Primary Emphasis on Pharmacologic Therapy: Part 3Pacing and Clinical Electrophysiology, 1998
- Rhythm Management in Atrial Fibrillation—with a Primary Emphasis on Pharmacological Therapy: Part 2Pacing and Clinical Electrophysiology, 1998
- Rhythm Management in Atrial Fibrillation—With a Primary Emphasis on Pharmacological Therapy: Part 1Pacing and Clinical Electrophysiology, 1998
- Efficacy and Safety of Repeated Intravenous Doses of Ibutilide for Rapid Conversion of Atrial Flutter or FibrillationCirculation, 1996
- Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose-response studyJournal of the American College of Cardiology, 1996
- Management of Patients With Atrial FibrillationCirculation, 1996
- Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainidePublished by Elsevier ,1994
- Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertensionPublished by Elsevier ,1992